
    
      This was a 6-month, randomized, open-label, active-comparator controlled, parallel-group
      study with a 6-month extension to evaluate the safety and efficacy of alendronate sodium 70
      mg plus vitamin D3 5600 IU combination tablets versus calcitriol in the treatment of
      osteoporosis in postmenopausal women in China. Participants were randomly assigned to receive
      alendronate 70 mg plus vitamin D3 5600 IU combination tablet once weekly orally or calcitriol
      0.25 Î¼g daily orally.
    
  